Noked Israel’s Chemed CHE Stock Holding History

Noked Israel’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-600	Closed	-$264K	–	20
2019 Q4	$264K	Sell	600 -250	-29%	-$105K	0.3%	46
2019 Q3	$355K	Buy	+850	New	+$347K	0.37%	22

Other funds holding CHE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Noked Israel's CHE Position: Q1 2020 in Review

Noked Israel sold out of Chemed (CHE) in Q1 2020, closing a stake of 600 shares — an estimated $264K sold.

Noked Israel first reported a position in CHE in Q3 2019 and held it in 2 quarters. The position peaked at $355K in Q3 2019. 412 funds tracked by Wall St. Rank hold CHE as of Q1 2020.

Noked Israel reported no remaining Chemed position as of Q1 2020 after selling out during the quarter.
Noked Israel sold 600 Chemed shares in Q1 2020, an estimated $264K.
Noked Israel first reported a position in Chemed in Q3 2019 and held it in 2 quarters.
Noked Israel's Chemed position peaked at $355K in Q3 2019.
412 funds tracked by Wall St. Rank held Chemed as of Q1 2020.

Based on Noked Israel's 13F filing for Q1 2020, filed 26 May 2020.